Paper36935493
Theranostic applications of selenium nanomedicines against lung cancer.
Liu S and 3 others. J Nanobiotechnology, 2023. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. Theranostic applications of selenium nanomedicines against lung cancer. Papers, record 36935493. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36935493
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Selenium | Major topic |
| Lung Neoplasms | Major topic |
| Nanoparticles | Major topic |
| Humans | |
| Precision Medicine | |
| Nanomedicine | |
| Antioxidants | |
| Drug Carriers |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022A1515010516 | Natural Science Foundation of Guangdong Province | PubMed | ||
| 2060206 | Guangzhou Science and Technology Planning Project | PubMed |
Source PubMed
References272
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24048973 | Near-infrared light-mediated nanoplatforms for cancer thermo-chemotherapy and optical imaging. | Adv Mater | 2013 | https://conductscience.org/library/papers/24048973 | PubMed |
| 2 | 24031517 | Biosynthesis of selenium nanoparticles using Klebsiella pneumoniae and their recovery by a simple sterilization process. | Braz J Microbiol | 2010 | https://conductscience.org/library/papers/24031517 | PubMed |
| 3 | 15073137 | Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. | Clin Cancer Res | 2004 | https://conductscience.org/library/papers/15073137 | PubMed |
| 4 | 27664248 | 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. | Ann Oncol | 2016 | https://conductscience.org/library/papers/27664248 | PubMed |
| 5 | 29692609 | Nano-selenium and its nanomedicine applications: a critical review. | Int J Nanomedicine | 2018 | https://conductscience.org/library/papers/29692609 | PubMed |
| 6 | 30259015 | Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. | Chem Soc Rev | 2019 | https://conductscience.org/library/papers/30259015 | PubMed |
| 7 | 18339032 | Effect of vitamin E and selenium supplementation on oxidative stress status in pulmonary tuberculosis patients. | Respirology | 2008 | https://conductscience.org/library/papers/18339032 | PubMed |
| 8 | 33207094 | First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer. | N Engl J Med | 2020 | https://conductscience.org/library/papers/33207094 | PubMed |
| 9 | 10727187 | Magnetic resonance imaging cranial and cerebral dimensions: is there a relationship with Chiari I malformation? A preliminary report in children. | Eur J Paediatr Neurol | 1999 | https://conductscience.org/library/papers/10727187 | PubMed |
| 10 | 27357069 | Olmutinib: First Global Approval. | Drugs | 2016 | https://conductscience.org/library/papers/27357069 | PubMed |
| 11 | 24385361 | Reduction of organic and inorganic selenium compounds by the edible medicinal basidiomycete Lentinula edodes and the accumulation of elemental selenium nanoparticles in its mycelium. | J Microbiol | 2013 | https://conductscience.org/library/papers/24385361 | PubMed |
| 12 | 23479319 | Effect of selenium and vitamin C on clinical outcomes, trace element status, and antioxidant enzyme activity in horses with acute and chronic lower airway disease. A randomized clinical trial. | Biol Trace Elem Res | 2013 | https://conductscience.org/library/papers/23479319 | PubMed |
| 13 | 26155316 | Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines. | Theranostics | 2015 | https://conductscience.org/library/papers/26155316 | PubMed |
| 14 | 30257326 | Synergistic combination of PEGylated selenium nanoparticles and X-ray-induced radiotherapy for enhanced anticancer effect in human lung carcinoma. | Biomed Pharmacother | 2018 | https://conductscience.org/library/papers/30257326 | PubMed |
| 15 | 19146838 | Caspase- and p53-dependent apoptosis in breast carcinoma cells induced by a synthetic selenadiazole derivative. | Chem Biol Interact | 2009 | https://conductscience.org/library/papers/19146838 | PubMed |
| 16 | 18405881 | Treatment of lung cancer cells with cytotoxic levels of sodium selenite: effects on the thioredoxin system. | Biochem Pharmacol | 2008 | https://conductscience.org/library/papers/18405881 | PubMed |
| 17 | 27264551 | Nanotechnology in hyperthermia cancer therapy: From fundamental principles to advanced applications. | J Control Release | 2016 | https://conductscience.org/library/papers/27264551 | PubMed |
| 18 | 23896004 | Near-IR-triggered photothermal/photodynamic dual-modality therapy system via chitosan hybrid nanospheres. | Biomaterials | 2013 | https://conductscience.org/library/papers/23896004 | PubMed |
| 19 | 33671134 | p38 MAPK Inhibition Mitigates Hypoxia-Induced AR Signaling in Castration-Resistant Prostate Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33671134 | PubMed |
| 20 | 31469318 | Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy. | Artif Cells Nanomed Biotechnol | 2019 | https://conductscience.org/library/papers/31469318 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943298 | Selenium Nanoparticles Functionalized with Tumor-Targeting Peptides for Lung Cancer Therapy: A Comprehensive Review. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943298 | PubMed |
| 42801166 | Promising Roles of Selenium Nanoparticles in Anti-Tuberculosis Therapy: Opportunities and Challenges. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42801166 | PubMed |
| 42588521 | Progress in the Synthesis of Organoselenium Compounds: Conventional Routes Versus Green Approaches. | Molecules | 2026 | https://conductscience.org/library/papers/42588521 | PubMed |
| 42023987 | Selenium-Based Nanoplatforms: An Emerging Theranostic Paradigm for Gynecological Cancers. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42023987 | PubMed |
| 41909506 | Translational selenium nanoparticles trigger apoptosis in triple-negative breast cancer cells through the MAPKs/Bcl2 pathway. | Bioact Mater | 2026 | https://conductscience.org/library/papers/41909506 | PubMed |
| 41737035 | Recent Progress in Selenium Nanomedicines for Ocular Diseases. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41737035 | PubMed |
| 41635496 | Organoselenium-based Schiff bases and amidic acid derivatives as promising anticancer agents targeting breast cancer by downregulating BCL-2: design, synthesis, and biological evaluation. | RSC Adv | 2026 | https://conductscience.org/library/papers/41635496 | PubMed |
| 41409250 | Deciphering molecular pathways driving cancer invasion and metastasis: advances and therapeutic prospects. | Front Oncol | 2025 | https://conductscience.org/library/papers/41409250 | PubMed |
| 41398607 | Targeting VSMCs to suppress macrophage-like phenotype switching that restrains atherogenesis by immunosuppressive oligodeoxynucleotide (A151) functionalized selenium nanoparticles. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/41398607 | PubMed |
| 41340872 | Astragalin: A promising herbal compound with broad anticancer potential (Review). | Oncol Lett | 2026 | https://conductscience.org/library/papers/41340872 | PubMed |
| 41195294 | Tumor-Associated Macrophages in Lung Cancer: Origins, Functional Heterogeneity, and Therapeutic Implications. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/41195294 | PubMed |
| 41007440 | Selenium and Mammalian Uterine Health: A Comprehensive Review. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/41007440 | PubMed |
| 40893247 | Aptamer-Functionalized Redox-Responsive Mesoporous Organosilica-Coated Selenium Nanoparticles for Targeted Therapy of Triple-Negative Breast Cancer Cells. | ACS Omega | 2025 | https://conductscience.org/library/papers/40893247 | PubMed |
| 40877308 | In vivo mechanisms of resveratrol liposomes in targeting the TLR4/NLRP3 pathway in lung cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/40877308 | PubMed |
| 40807660 | Preparation and Characterization of Cyperus-Derived Exosomes Loaded with Selenium Nanoparticles for Selenium Delivery Based on Exosome Protein Quantitation. | Foods | 2025 | https://conductscience.org/library/papers/40807660 | PubMed |
| 40563308 | Harnessing Antioxidants in Cancer Therapy: Opportunities, Challenges, and Future Directions. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40563308 | PubMed |
| 40404704 | Associations of biological aging with the morbidity and all-cause mortality of patients with lung cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/40404704 | PubMed |
| 40298842 | Selenium-Binding Protein 1-Deficient Dendritic Cells Protect Mice from Sepsis by Increased Treg/Th17. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40298842 | PubMed |
| 40229875 | Translational selenium nanomedicine synergizes with nab-paclitaxel to enhance antitumor effects in esophageal squamous cell cancer via selenoprotein N-mediated ER stress. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40229875 | PubMed |
| 40100580 | Development and validation of M2 macrophage-related genes in a prognostic model of lung adenocarcinoma based on bulk RNA and ScRNA datasets. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40100580 | PubMed |
Genes35
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36935493
GET https://conductscience.org/api/papers/v1/36935493/references?page=2